Erminia Dellaporta, Lazaros-Dimitrios Lazaridis, Vasilleios Koussoulas, Mihai G Netea, Evangelos J. Giamarellos-Bourboulis, Konstantinos Triantafyllou

Medicine 2019 Jun;98(23):e15913
DOI 10.1097/MD.0000000000015913


M.G. Netea is supported by a Dutch Vici grant. E.J. Giamarellos-Bourboulis has received honoraria (paid to the University of Athens) from AbbVie, Biotest, Brahms GmbH, and The Medicines Company; has received compensation as a consultant for Astellas Greece and for XBiotech (paid to the University of Athens); and has received independent educational grants (paid to the University of Athens) from AbbVie, InflaRx, and Sanofi. He is funded by the FrameWork 7 program HemoSpec and by the Horizon 2020 Marie-Curie grant European Sepsis Academy (granted to the University of Athens).

Keywords: inflammatory bowel disease; NLRP12; single nucleotide polymorphisms; TNFa